Analyst Research

Report Title Price
Provider: New Constructs, LLC
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Albany Molecular Research Inc acquires Cedarburg Pharmaceuticals Inc

Monday, 24 Mar 2014 07:00am EDT 

Albany Molecular Research Inc:Acquires all outstanding shares of Cedarburg Pharmaceuticals Inc. for $38.2 mln in cash.Transaction including $2.8 mln of assumed liabilities, is valued at $41 mln.Transaction is consistent with AMRI's strategy to be preeminent supplier of custom and complex drug development services and product to both branded and generic pharmaceutical industry. 

Company Quote

0.09 +0.45%
29 Aug 2014